Free Trial

Artelo Biosciences (ARTL) Short Interest Ratio & Short Volume

$1.37
-0.02 (-1.44%)
(As of 07/26/2024 ET)

Artelo Biosciences Short Interest Data

Current Short Interest
1,200 shares
Previous Short Interest
14,100 shares
Change Vs. Previous Month
-91.49%
Dollar Volume Sold Short
$1,596.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
July 15, 2024
Outstanding Shares
3,230,000 shares
Float Size
3,200,000 shares
Short Percent of Float
0.04%
Today's Trading Volume
3,416 shares
Average Trading Volume
45,839 shares
Today's Volume Vs. Average
7%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Artelo Biosciences ?

Sign up to receive the latest short interest report for Artelo Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ARTL Short Interest Over Time

ARTL Days to Cover Over Time

ARTL Percentage of Float Shorted Over Time

Artelo Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20241,200 shares $1,596.00 -91.5%0.0%0 $1.33
6/30/202414,100 shares $18,894.00 +2.9%0.4%1.2 $1.34
6/15/202413,700 shares $18,769.00 +39.8%0.4%1.2 $1.37
5/31/20249,800 shares $13,426.00 +58.1%0.3%0.7 $1.37
5/15/20246,200 shares $8,184.62 +26.5%0.2%0.4 $1.32
4/30/20244,900 shares $6,739.95 -19.7%0.2%0.3 $1.38
4/15/20246,100 shares $9,028.00 -57.9%0.2%0.4 $1.48
3/31/202414,500 shares $21,460.00 -28.2%0.5%0.9 $1.48
3/15/202420,200 shares $29,088.00 +9.2%0.6%1.1 $1.44
2/29/202418,500 shares $28,305.00 +117.7%0.6%1.1 $1.53
2/15/20248,500 shares $14,705.00 -38.9%0.3%0.5 $1.73
1/31/202413,900 shares $19,460.00 -3.5%0.4%0.8 $1.40
1/15/202414,400 shares $21,024.00 -0.7%0.5%0.7 $1.46
12/31/202314,500 shares $20,300.00 -44.9%0.5%0.5 $1.40
12/15/202326,300 shares $35,505.00 -18.1%0.8%0.9 $1.35
11/30/202332,100 shares $45,582.00 +9.9%1.0%0.9 $1.42
11/15/202329,200 shares $37,668.00 +3.6%0.9%0.1 $1.29
10/31/202328,200 shares $34,827.00 -56.4%1.0%0.1 $1.24
10/15/202364,700 shares $92,521.00 +34.8%2.3%0.2 $1.43
9/30/202348,000 shares $70,080.00 -42.7%1.7%0.2 $1.46
9/15/202383,800 shares $128,214.00 +357.9%2.9%0.3 $1.53
8/31/202318,300 shares $34,404.00 +8.9%0.6%0.1 $1.88
8/15/202316,800 shares $33,768.00 -21.9%0.6%1.3 $2.01
7/31/202321,500 shares $41,065.00 -16.7%0.8%1.7 $1.91
7/15/202325,800 shares $51,084.00 -21.8%0.9%1.4 $1.98
6/30/202333,000 shares $66,330.00 +4.4%1.2%1.8 $2.01
6/15/202331,600 shares $64,464.00 +10.5%1.1%1.5 $2.04
5/31/202328,600 shares $51,079.60 +6.7%1.0%1.4 $1.79
5/15/202326,800 shares $45,828.00 +48.9%1.0%1.3 $1.71
4/30/202318,000 shares $29,340.00 -77.3%0.6%0.8 $1.63
4/15/202379,300 shares $206,608.22 +16.3%2.8%4.2 $2.61
3/31/202368,200 shares $158,224.00 +75.3%2.4%3.3 $2.32
3/15/202338,900 shares $89,470.00 -30.3%1.4%1.8 $2.30
2/28/202355,800 shares $159,867.00 -26.0%2.0%2.5 $2.87
2/15/202375,400 shares $226,954.00 +40.2%2.7%3.3 $3.01
1/31/202353,800 shares $173,236.00 -34.5%1.9%2.2 $3.22
1/15/202382,100 shares $267,646.00 -22.9%2.9%3.5 $3.26
12/30/2022106,500 shares $307,785.00 -16.2%3.7%4.8 $2.89
12/15/2022127,100 shares $374,945.00 +37.0%4.5%6.2 $2.95
11/30/202292,800 shares $228,288.00 +4.3%3.3%3.6 $2.46
Get out of cash before the Fed's next meeting (Ad)

"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."

Click here now to watch this exclusive interview
11/15/202289,000 shares $258,990.00 +11.1%3.1%2.3 $2.91
10/31/202280,100 shares $229,887.00 +11.3%2.8%0.2 $2.87
10/15/202272,000 shares $228,240.00 -4.9%2.5%0.2 $3.17
9/30/202275,700 shares $261,165.00 +30.1%2.7%0.2 $3.45
9/15/202258,200 shares $240,948.00 +39.6%2.1%0.2 $4.14
8/31/202241,700 shares $160,545.00 -33.7%1.5%0.1 $3.85
8/15/202262,900 shares $274,244.00 -91.5%2.2%0.2 $4.36
7/31/2022737,000 shares $250,653.70 -17.1%N/A2.2 $0.34
7/15/2022888,500 shares $302,090.00 -2.4%N/A2.7 $0.34
6/30/2022910,500 shares $288,446.40 +8.0%N/A0.7 $0.32
6/15/2022843,300 shares $266,651.46 -15.7%N/A0.6 $0.32
5/31/20221,000,000 shares $331,000.00 +80.6%N/A0.7 $0.33
5/15/2022553,600 shares $183,241.60 -31.3%N/A0.4 $0.33
4/30/2022806,300 shares $308,006.60 +19.4%N/A0.6 $0.38
4/15/2022675,600 shares $290,508.00 -30.0%N/A0.5 $0.43
3/31/2022964,800 shares $434,160.00 +45.6%N/A1.8 $0.45
3/15/2022662,700 shares $265,080.00 +21.2%N/A1.2 $0.40
2/28/2022546,800 shares $217,243.64 -19.1%N/A0.9 $0.40
2/15/2022675,700 shares $261,901.32 +35.4%N/A0.9 $0.39
1/31/2022499,000 shares $209,580.00 -37.4%N/A0.4 $0.42
1/15/2022797,200 shares $350,768.00 +4.8%N/A0.1 $0.44
12/31/2021760,700 shares $394,803.30 -1.8%N/A0.1 $0.52
12/15/2021774,300 shares $446,848.53 -4.6%N/A0.1 $0.58
11/30/2021811,900 shares $511,497.00 -36.1%N/A0.1 $0.63
11/15/20211,270,000 shares $1.08 million +69.7%N/A0.2 $0.85
10/29/2021748,300 shares $535,782.80 -9.8%N/A0.1 $0.72
10/15/2021829,800 shares $634,797.00 -4.3%N/A2.8 $0.77
9/30/2021866,600 shares $685,047.30 -27.8%N/A2.9 $0.79
9/15/20211,200,000 shares $990,000.00 -2.4%N/A3.5 $0.83
8/31/20211,230,000 shares $1.12 million -13.4%N/A3.1 $0.91
8/13/20211,420,000 shares $1.23 million -13.4%N/A3 $0.87
7/30/20211,640,000 shares $1.64 million -6.8%N/A3.4 $1.00
7/15/20211,760,000 shares $1.81 million +4.8%N/A3.7 $1.03
6/30/20211,680,000 shares $2.00 million +0.6%N/A2.7 $1.19
6/15/20211,670,000 shares $1.95 million +3.1%7.6%2.5 $1.17
5/28/20211,620,000 shares $2.01 million -1.8%7.4%1.8 $1.24
5/14/20211,650,000 shares $1.86 million -4.1%N/A1.1 $1.13
4/30/20211,720,000 shares $2.29 million -6.5%N/A0.3 $1.33
4/15/20211,840,000 shares $2.34 million -13.2%N/A0.2 $1.27
3/31/20212,120,000 shares $3.31 million -17.2%N/A0.2 $1.56
3/15/20212,560,000 shares $5.04 million -10.2%N/A0.3 $1.97
2/26/20212,850,000 shares $5.56 million +0.4%N/A0.3 $1.95
2/12/20212,840,000 shares $4.63 million +49.5%N/A0.3 $1.63
1/29/20211,900,000 shares $1.71 million +79.3%N/A0.5 $0.90
1/15/20211,060,000 shares $1.07 million +54.0%N/A0.4 $1.01
12/31/2020688,400 shares $481,122.76 +16.1%N/A0.3 $0.70
12/15/2020592,900 shares $391,314.00 +3.1%N/A0.3 $0.66
11/30/2020575,200 shares $345,120.00 +2.4%N/A0.3 $0.60
11/15/2020562,000 shares $292,296.20 -39.9%N/A0.3 $0.52
10/30/2020934,400 shares $466,732.80 +201.7%N/A0.6 $0.50
Get out of cash before the Fed's next meeting (Ad)

"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."

Click here now to watch this exclusive interview
10/15/2020309,700 shares $240,884.66 +113.6%N/A0.2 $0.78
9/30/2020145,000 shares $143,927.00 -9.3%N/A0.2 $0.99
9/15/2020159,900 shares $140,712.00 +32.0%4.8%0.3 $0.88
8/31/2020121,100 shares $116,256.00 +76.5%3.6%0.2 $0.96
8/14/202068,600 shares $78,890.00 +127.9%2.1%0.2 $1.15
7/31/202030,100 shares $34,615.00 +30.3%1.0%0.1 $1.15
7/15/202023,100 shares $25,410.00 +266.7%0.8%0.1 $1.10
6/30/20206,300 shares $7,623.00 +26.0%0.3%0 $1.21
6/15/20205,000 shares $6,300.00 -70.9%0.2%0 $1.26
5/29/202017,200 shares $22,016.00 +352.6%0.8%0.1 $1.28
5/15/20203,800 shares $4,180.00 -84.9%0.2%0 $1.10
4/30/202025,200 shares $31,497.48 +31.9%1.1%0.2 $1.25
4/15/202019,100 shares $26,358.00 -0.5%N/A0.1 $1.38
3/31/202019,200 shares $22,080.00 +28.0%N/A0.1 $1.15
3/13/202015,000 shares $15,150.00 +383.9%N/A0.3 $1.01
2/28/20203,100 shares $2,883.00 No ChangeN/A0 $0.93
2/14/20203,100 shares $3,379.00 -63.5%0.1%0 $1.09
1/31/20208,500 shares $10,455.00 -53.6%0.4%0 $1.23
1/15/202018,300 shares $25,986.00 -62.8%1.0%0.3 $1.42
12/31/201949,200 shares $112,668.00 +140.0%2.6%0.8 $2.29

ARTL Short Interest - Frequently Asked Questions

What is Artelo Biosciences' current short interest?

Short interest is the volume of Artelo Biosciences shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 1,200 shares of ARTL short. 0.04% of Artelo Biosciences' shares are currently sold short. Learn More on Artelo Biosciences' current short interest.

What is a good short interest percentage for Artelo Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of Artelo Biosciences' floating shares are currently sold short.

Is Artelo Biosciences' short interest increasing or decreasing?

Artelo Biosciences saw a decline in short interest in July. As of July 15th, there was short interest totaling 1,200 shares, a decline of 91.5% from the previous total of 14,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Artelo Biosciences' float size?

Artelo Biosciences currently has issued a total of 3,230,000 shares. Some of Artelo Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Artelo Biosciences currently has a public float of 3,200,000 shares.

How does Artelo Biosciences' short interest compare to its competitors?

0.04% of Artelo Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Artelo Biosciences: Aptorum Group Limited (0.08%), VBI Vaccines Inc. (1.08%), PharmaCyte Biotech, Inc. (0.19%), Unicycive Therapeutics, Inc. (3.08%), Kiora Pharmaceuticals, Inc. (0.67%), Imunon, Inc. (2.99%), Cardio Diagnostics Holdings, Inc. (1.57%), Eterna Therapeutics Inc. (1.84%), PHAXIAM Therapeutics S.A. (0.01%), RedHill Biopharma Ltd. (1.07%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

What does it mean to sell short Artelo Biosciences stock?

Short selling ARTL is an investing strategy that aims to generate trading profit from Artelo Biosciences as its price is falling. ARTL shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Artelo Biosciences?

A short squeeze for Artelo Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARTL, which in turn drives the price of the stock up even further.

How often is Artelo Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARTL, twice per month. The most recent reporting period available is July, 15 2024.



This page (NASDAQ:ARTL) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners